Literature DB >> 3053609

Efficacy and safety of fenfluramine in autistic children.

M Campbell, P Adams, A M Small, E L Curren, J E Overall, L T Anderson, N Lynch, R Perry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3053609     DOI： 10.1097/00004583-198807000-00010

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  8 in total

1.  Brief report: effects of fenfluramine on communicative, stereotypic, and inappropriate behaviors of autistic-type mentally handicapped individuals.

Authors:  P C Duker; K Welles; D Seys; H Rensen; A Vis; G van den Berg
Journal:  J Autism Dev Disord       Date:  1991-09

Review 2.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

3.  An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.

Authors:  Craig A Erickson; Maureen Early; Kimberly A Stigler; Logan K Wink; Jennifer E Mullett; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

4.  The effects of fenfluramine (hydrochloride) on the behaviors of fifteen autistic children.

Authors:  J Sherman; D C Factor; R Swinson; R W Darjes
Journal:  J Autism Dev Disord       Date:  1989-12

5.  Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.

Authors:  M G Aman; R A Kern; D E McGhee; L E Arnold
Journal:  J Autism Dev Disord       Date:  1993-09

Review 6.  Pharmacotherapy for the core symptoms in autistic disorder: current status of the research.

Authors:  Cristan Farmer; Audrey Thurm; Paul Grant
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 7.  Developing drugs for core social and communication impairment in autism.

Authors:  David J Posey; Craig A Erickson; Christopher J McDougle
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

8.  Movement Disorders Secondary to Novel Antiseizure Medications in Pediatric Populations: A Systematic Review and Meta-analysis of Risk.

Authors:  Dakota J S J Peacock; Joshua R K Yoneda; Jodi E Siever; Mathew Vis-Dunbar; Cyrus Boelman
Journal:  J Child Neurol       Date:  2022-04-07       Impact factor: 2.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.